BLU

Is BLU a Buy, Before Earnings?

PremiumPre-Earnings

2y ago

Pliant Therapeutics pullback on ‘really strong data’ unjustified, says Piper

PremiumThe Fly

2y ago

Largest borrow rate increases among liquid names

PLRX

PremiumThe Fly

2y ago

AMC

PremiumThe Fly

Bellus Health downgraded to Hold from Buy at Jefferies

2y ago

PremiumThe FlyBellus Health management to meet with Piper Sandler

2y ago

Bellus Health cut to Sector Perform at RBC Capital on GSK deal

The Fly

Bellus Health cut to Sector Perform at RBC Capital on GSK deal

2y ago

Bellus Health downgraded to Sector Perform from Outperform at RBC Capital

The Fly

Bellus Health downgraded to Sector Perform from Outperform at RBC Capital

2y ago

Bellus Health downgraded to In Line from Outperform at Evercore ISI

PremiumThe Fly

2y ago

GSK to acquire Bellus Health for $14.75 per share

PremiumThe Fly

2y ago

Bellus Health Surges after Acquisition by GSK for $2 Billion

PremiumMarket News

2y ago

Bellus Health management to meet with Piper Sandler

PremiumThe Fly

2y ago

PremiumThe FlyBellus Health announces results from camlipixant bioavailability study

2y ago

Bellus Health reports FY22 EPS (66c), consensus (70c)

The Fly

Bellus Health reports FY22 EPS (66c), consensus (70c)

2y ago

Bellus Health reports Q3 EPS (20c), consensus (17c)

The Fly

Bellus Health reports Q3 EPS (20c), consensus (17c)

2y ago

2 Monster Growth Stocks That Could Reach New Highs

PremiumStock Analysis & Ideas

2y ago

BELLUS Shares Have More Room to Run, Says Analyst

COGT

PremiumStock Analysis & Ideas

3y ago

BELLUS Health: Drug Trial Results SOOTHE the Market

PremiumStock Analysis & Ideas

3y ago

2 “Strong Buy” Penny Stocks That Could Rally Over 100%

PremiumStock Analysis & Ideas

4y ago

OBSV

PremiumMarket NewsBellus Health Craters 72% On Chronic Cough Miss; Analyst Still Says Buy

4y ago